Research suggests that prior authorization has negative effects on patients with cancer and oncology providers.

Unemployment, neurological deficit, and some treatments increase the likelihood adult survivors of childhood cancer retain a fear of recurrence or SMN.

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

For disease-specific survival in malignant adnexal tumors of the skin, Mohs micrographic surgery is superior to wide local excision and no treatment.

The per member per month (PMPM) health care costs for members with insomnia were 4 to 6 times higher than those without insomnia.

Psilocybin-assisted psychotherapy can help patients with cancer with a range of psychiatric symptoms, according to a recent study.

Native Hawaiian and Pacific Islander adults have a high rate of cardiovascular disease mortality, according to study findings.

In the phase 4 FOREMOST trial, treatment with apremilast improved both clinical and patient-reported outcomes at week 16 among patients with early oligoarticular PsA.

The MVA-BN vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents.

Precocious puberty is associated with approximately 2-fold greater odds of hidradenitis suppurativa, regardless of patient-specific characteristics.

Two different doses of sebetralstat significantly reduced anxiety compared with placebo during hereditary angioedema (HAE) attacks.

Patients with idiopathic inflammatory myopathies, particularly polymyositis, show a high prevalence of atherosclerotic CVD.